Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dan Adrian Popica has a total of 112 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Repeat Woven EndoBridge Implantation for Recurrent Intracranial Aneurysms: Experience from a Consecutive Single-Center Cohort

    by Taisuke Akimoto, Cristian Mihalea, Fernanda Rodriguez Erazu, Julia Juhasz, Mohamed Ismail, Dan Adrian Popica, Daniel Claudiu Malita, Vanessa Chalumeau, Léon Ikka, Jildaz Caroff, et al.

  • Predictive factors of delayed braid deformation in DFT flow diverters

    by Fernanda Rodriguez-Erazú, Jildaz Caroff, Dan Adrian Popica, Andrés Silva-Pozo, Hugo Cadilha, Mohamed Ismail, Vincent Plaforet, Ignacio Molina Diaz, Vanessa Chalumeau, Léon Ikka, et al.

    Background: Concerns have arisen regarding flow diverter braid deformation (FDBD), particularly with last-generation platinum drawn-filled tube (DFT) wire devices. Braid deformation is likely multifactorial, influenced by patient characteristics, device selection, and procedural factors, yet no clinical analysis has systematically identified predictive factors. We conducted a study to determine the incidence, patterns, and predictors of braid deformation with these devices. Methods: Consecutive intracranial aneurysms treated with various flow diverters (FDs) constructed with DFT wires between June 2018 and June 2024 were included. High-resolution cone-beam CT with diluted contrast (vasoCT) and angiograms were reviewed to identify and classify FDBD following international consensus definitions. Patient, aneurysm, anatomy, procedural, and FD characteristics were retrieved and analyzed using univariate and multivariable analyses. Results: A total of 102 patients were included. FDBD was observed in 28 patients (27%), comprising 41 deformations. Three independent predictors of FDBD were identified: short distal landing zone (aOR 0.80, 95% CI 0.63 to 0.98; P=0.04), FD proximal oversizing (aOR 40.05, 95% CI 5.14 to 405.23; P<0.01), and younger age (aOR 0.93, 95% CI 0.88 to 0.98; P<0.01). Internal carotid artery aneurysms were also associated with FDBD in the univariate analysis (P<0.05). Conclusion: FDBD with DFT FDs is a frequent phenomenon observed in about 1/4 cases, associated with symptomatic complications but without affecting permanent morbidity. Patient age and technical factors such as short landing zone and FD oversizing were independent predictors of FDBD. This analysis may help to guide operator decisions when using DFT FDs and support future research in this field.


  • Open Access

    Detection of esophageal varices and prediction of hepatic decompensation in unresectable hepatocellular carcinoma using AI

    by Asier Rabasco Meneghetti, Claudia Campani, Charles Roux, Zunamys I. Carrero, Dan-Adrian Popica, Giuliana Amaddeo, Marie Lequoy, Clémence Hollande, Sarah Mouri, Mathilde Wagner, et al.


  • Open Access

    Impact of M2-segment occlusion angiographic shape on recanalization and clinical outcomes in mechanical thrombectomy

    by Osama Elshafei, Jonathan Cortese, Ali Gaber, Eman Eltantawy, Adrian Dan Popica, Léon Ikka, Cristian Mihalea, Vanessa Chalumeau, Mariana Sarov, Olivier Chassin, et al.


  • Initial Experience with the Pipeline Vantage Flow Diverter for Intracranial Aneurysms: A Systematic Review and Meta-Analysis

    by Jonathan Cortese, Sherief Ghozy, Parya Valizadeh, Alireza Hasanzadeh, Melika Amoukhteh, Payam Jannatdoust, Amir Hassankhani, Ali Ahmadzade, Dan Adrian Popica, David F. Kallmes, et al.

    Background: The Pipeline Vantage Flow diverter (Vantage) is the latest generation of Pipeline flow diverters introducing Cobalt-chronium drawn-filled tubing and 48 to 68 wires. Purpose: We report the initial safety and efficacy of Vantage in treating intracranial aneurysms in the published literature. Data Sources: A systematic review and meta-analysis was conducted according to established protocols. Searches were conducted in PubMed, Scopus, Web-of-Science, and Embase databases up to December 2023. Original studies reporting treatment outcomes for intracranial aneurysms using Vantage in more than five patients were included. Study Selection: Pooled data from 5 studies (373 patients, 418 aneurysms) were analyzed. Data Analysis: Outcomes of interest were: technical success, occlusion rates, complication outcomes and mortality. Data Synthesis: A technical success rate of 99.2% (95% CI: 98.29%–100%) was found. In unruptured cases, success rate was 378/383 (99.6%) versus 17/20 (85.0%) in ruptured cases (P < .01). Complete occlusion rate was 74.3% (95% CI: 67.43%–80.59%), with no significant difference between ruptured and unruptured cases (P = 0.72); median of follow up 6 months. Overall mortality rate was 1.2% (95% CI: 0.01%–3.64%), significantly higher in ruptured (18.6%; 95% CI: 5.13%–36.26%) versus unruptured cases (0.23%; 95% CI: 0%–1.36%) (P < 0.01). Hemorrhagic complications occurred at 1% (95% CI: 0%–3.36%) pooled rate. Thromboembolic complications were reported at 6.1% (95% CI: 2.60%–10.73%), decreasing to 4.35% (95% CI: 1.91%–7.54%) after excluding one outlier study. Limitations: Only five studies, some with small number of patients, were included in this meta-analysis which may limit the generalizability of our findings. The absence of long term follow-up also limits the assessment of treatment durability. Conclusions: In this meta-analysis, we found that Vantage initial experience is similar to previous version of the Pipeline Embolization Device in terms of safety and efficacy for treatment of intracranial aneurysms, in particular unruptured aneurysms. Further prospective and comparative studies with patient outcome data specific to aneurysm location are needed to confirm the safety and efficacy of Vantage.


  • Open Access

    Iatrogenic arterial vasospasm during mechanical thrombectomy requiring treatment with intra‐arterial nimodipine might be associated with worse outcomes

    by Serine Ferhat, Guillaume Bellanger, Malgorzata Milnerowicz, Maeva Kyheng, Julien Labreuche, Igor Sibon, Mehdi Khobzi, Joe‐Marie Abousleiman, Dan‐Adrian Popica, Solene Moulin, et al.

    Background and Purpose: Vasospasm is a common iatrogenic event during mechanical thrombectomy (MT). In such circumstances, intra‐arterial nimodipine administration is occasionally considered. However, its use in the treatment of iatrogenic vasospasm during MT has been poorly studied. We investigated the impact of iatrogenic vasospasm treated with intra‐arterial nimodipine on outcomes after MT for large vessel occlusion stroke.Methods: We conducted a retrospective analysis of the multicenter observational registry Endovascular Treatment in Ischemic Stroke (ETIS). Consecutive patients treated with MT between January 2015 and December 2022 were included. Patients treated with medical treatment alone, without MT, were excluded. We also excluded patients who received another in situ vasodilator molecule during the procedure. Outcomes were compared according to the occurrence of cervical and/or intracranial arterial vasospasm requiring intraoperative use of in situ nimodipine based on operator's decision, using a propensity score approach. The primary outcome was a modified Rankin Scale (mRS) score of 0–2 at 90 days. Secondary outcomes included excellent outcome (mRS score 0–1), final recanalization, mortality, intracranial hemorrhage and procedural complications. Secondary analyses were performed according to the vasospasm location (intracranial or cervical).Results: Among 13,678 patients in the registry during the study period, 434 received intra‐arterial nimodipine for the treatment of MT‐related vasospasm. In the main analysis, comparable odds of favorable outcome were observed, whereas excellent outcome was significantly less frequent in the group with vasospasm requiring nimodipine (adjusted odds ratio [aOR] 0.78, 95% confidence interval [CI] 0.63–0.97). Perfect recanalization, defined as a final modified Thrombolysis In Cerebral Infarction score of 3 (aOR 0.63, 95% CI 0.42–0.93), was also rarer in the vasospasm group. Intracranial vasospasm treated with nimodipine was significantly associated with worse clinical outcome (aOR 0.64, 95% CI 0.45–0.92), in contrast to the cervical location (aOR 1.37, 95% CI 0.54–3.08).Conclusion: Arterial vasospasm occurring during the MT procedure and requiring intra‐arterial nimodipine administration was associated with worse outcomes, especially in case of intracranial vasospasm. Although this study cannot formally differentiate whether the negative consequences were due to the vasospasm itself, or nimodipine administration or both, there might be an important signal toward a substantial clinical impact of iatrogenic vasospasm during MT.


  • Flow diverter braid deformation following treatment of cerebral aneurysms: incidence, clinical relevance, and potential risk factors

    by Dan Adrian Popica, Jonathan Cortese, Alexander A Oliver, Vincent Plaforet, Ignacio Molina Diaz, Fernanda Rodriguez-Erazú, Léon Ikka, Cristian Mihalea, Vanessa Chalumeau, David F Kallmes, et al.

    Background Although flow diverters (FDs) have benefited from several technical improvements, recently concerns have arisen regarding the braid stability after implantation. Thus, we investigated frequency, predictive factors, and clinical impact of the phenomenon of FD braid deformation (FDBD). Methods Consecutive intracranial aneurysms (IAs) treated with various FDs, between January 2018 and July 2023, were reviewed to identify FDBD (defined as the deformation of a FD without any external force applied to it). Patient, aneurysm, procedural, and FD characteristics were retrieved and analyzed using univariate and multivariable analyses. Morbidity is defined as a score of +1 in the modified Rankin Scale at 3 months. Results In total, 245 FD procedures (271 FDs implanted; 25 multiple IAs treated with 1 FD) in 228 patients; FDBD was observed in 36/245 cases (14.7%), mainly at follow-up angiography (32/36, 88.9%); fish-mouthing was the most frequent FDBD. Morbidity was related to fish-mouthing and braid collapse and was significantly higher in the FDBD group after retreatment (p=0.04). Drawn filled tubing with platinum (DFT) (adjusted odds ratio (aOR)=7.0, 95% CI 3.0 to 17.5; pConclusions FDBD is a frequent phenomenon observed in about 15% of cases, and it was responsible for higher morbidity. Only FD characteristics (DFT and FD diameter) were independent determinants of FDBD. Future research should focus on the impact of novel braid configurations and materials on braid stability.


  • Thromboembolic Events With the Woven Endobridge Device: Incidence, Predictive Factors, and Management

    by Fernanda Rodriguez-Erazú, Jonathan Cortese, Cristian Mihalea, Adrian Popica, Vanessa Chalumeau, Natalia Vasconcellos, Sophie Gallas, Leon Ikka, Lamiae Grimaldi, Jildaz Caroff, et al.

    BACKGROUND and OBJECTIVES: The Woven EndoBridge (WEB) device has been increasingly used to treat wide-neck aneurysms showing a safe and effective profile, but a relatively high number of thromboembolic events (TEEs) have been reported with such treatment. We aimed to evaluate the incidence and management of TEEs and possible predictive factors related to WEB embolization of ruptured and unruptured intracranial aneurysms. METHODS: A single-center database with consecutive aneurysms treated with a WEB device between July 2012 and May 2022 was reviewed for intraoperative and delayed TEEs. Univariate and multivariable analyses were used to determine factors associated with TEEs. RESULTS: A total of 266 independent aneurysms were treated with WEB devices in 245 patients (mean age 55.78 ± 11.64 years, 169 (63.5%) females, 80 (30%) ruptured). The overall rate of TEEs is 13% (35/266), including 8.7% intraoperative. Symptomatic TEEs with clinical sequelae at a 3-month follow-up are reported to be 2.6% (7/266) with no TEE-related mortality. Both the replacement of a WEB device during the procedure (adjusted odds ratio = 2.61, 95% CI 1.24-5.49; P = .01) and ruptured aneurysms (adjusted odds ratio = 2.74, 95% CI 1.31-5.7; P = .007) were independent predictors of TEEs. A case-by-case management of intraprocedural TEE is also presented; tirofiban was successfully used in most cases of this cohort. CONCLUSION: In this study, we demonstrated that ruptured aneurysms and WEB device replacement during the procedure were independent predictive factors for TEEs. As a result, making the correct choice of WEB is crucial for improving treatment outcomes. Moreover, with proper medical management of TEEs, minimal morbidity and no mortality could be achieved, which reinforces the safety of the technique.


  • The Bicêtre occlusion scale is well suited to assess the efficacy of the Contour embolization device

    by Jildaz Caroff, Jonathan Cortese, Francesco D'Argento, Dan Adrian Popica, Cristian Mihalea, Laurent Spelle